REFERENCES
1. Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg 2007;59:464-72.
2. Mihara M, Hara H, Hayashi Y, et al. Pathological steps of cancer-related lymphedema: histological changes in the collecting lymphatic vessels after lymphadenectomy. PLoS One 2012;7:e41126.
3. Yamamoto T, Yamamoto N, Yoshimatsu H, Narushima M, Koshima I. Factors associated with lymphosclerosis: an analysis on 962 lymphatic vessels. Plast Reconstr Surg 2017;140:734-41.
4. Granzow JW, Soderberg JM, Kaji AH, Dauphine C. Review of current surgical treatments for lymphedema. Ann Surg Oncol 2014;21:1195-201.
5. Calderwood A, Thompson B, Ho-shon K, Suami H. Overview of magnetic resonance lymphography for imaging lymphoedema. PAR 2021; doi: 10.20517/2347-9264.2021.14.
6. Yang JC, Wu SC, Chiang MH, Lin WC. Targeting reflux-free veins with a vein visualizer to identify the ideal recipient vein preoperatively for optimal lymphaticovenous anastomosis in treating lymphedema. Plast Reconstr Surg 2018;141:793-7.
7. Seki Y, Kajikawa A, Asai R, et al. Functional lymphaticovenular anastomosis for peripheral lymphedema: incision selection methods with muscle pumping. PAR 2021; doi: 10.20517/2347-9264.2021.80.
8. Garza RM, Beederman M, Chang DW. Physical and functional outcomes of simultaneous vascularized lymph node transplant and lymphovenous bypass in the treatment of lymphedema. Plast Reconstr Surg 2022;150:169-80.
9. Mitsumori LM, McDonald ES, Neligan PC, Maki JH. Peripheral magnetic resonance lymphangiography: techniques and applications. Tech Vasc Interv Radiol 2016;19:262-72.
10. Mazzei FG, Gentili F, Guerrini S, et al. MR lymphangiography: a practical guide to perform it and a brief review of the literature from a technical point of view. Biomed Res Int 2017;2017:2598358.
11. Hawkins CM. Building a radiology service line: key elements and necessary actions. Curr Probl Diagn Radiol 2016;45:107-10.
12. Guerrini S, Gentili F, Mazzei FG, Gennaro P, Volterrani L, Mazzei MA. Magnetic resonance lymphangiography: with or without contrast? Diagn Interv Radiol 2020;26:587-95.
13. Chan S. The importance of strategy for the evolving field of radiology. Radiology 2002;224:639-48.
14. White RD, Weir-McCall JR, Budak MJ, Waugh SA, Munnoch DA, Sudarshan TA. Contrast-enhanced magnetic resonance lymphography in the assessment of lower limb lymphoedema. Clin Radiol 2014;69:e435-44.
15. Notohamiprodjo M, Baumeister RG, Jakobs TF, et al. MR-lymphangiography at 3.0 T - a feasibility study. Eur Radiol 2009;19:2771-8.
16. Ripley B, Wilson GJ, Lalwani N, Briller N, Neligan PC, Maki JH. Initial clinical experience with dual-agent relaxation contrast for isolated lymphatic channel Mapping. Radiology 2018;286:705-14.
17. Maki JH, Neligan PC, Briller N, Mitsumori LM, Wilson GJ. Dark blood magnetic resonance lymphangiography using dual-agent relaxivity contrast (DARC-MRL): a novel method combining gadolinium and iron contrast agents. Curr Probl Diagn Radiol 2016;45:174-9.
18. U.S. Food & Drug Administration. FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol). Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-strengthens-warnings-and-changes-prescribing-instructions-decrease [Last accessed on 29 Jul 2022].
